JD Health International revenue and financials
$35.34Change from previous close: +0.57%Absolute change: +$0.20
In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +26.28%
- 2025 vs 2024
- Net income growth
- +29.16%
- 2025 vs 2024
- Net margin
- 7.3%
- 2024: 7.2%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2025 |
|---|---|
| Average shares (basic) | 3,200 |
| Average shares (diluted) | 3,200 |
